AI-driven discovery aims to speed development, improve delivery precision, and expand therapeutic potential of Circurna’s ciRNA™ circular RNA platformHOUSTON and IRVINE, Calif., Aug. 26, 2025 (GLOBE ...

RNA-binding proteins use a dual binding mechanism involving zinc finger (ZnF) domains and intrinsically disordered regions ...

Discover five South Korean biotechs that have received funding in recent years and are broadening R&D in various therapeutics ...

WPBF 25 goes "On the Record" on how local medical facilities are combating cancer.

Certain types of biochemical processes can impair the immune system's ability to recognize and kill cancer cells. Purdue ...

Partly focused on delivery challenges that have limited the reach of RNA medicines, new biotech company Axelyf Inc. closed a $2.6 million seed round to support development of its AXL technology and to ...

Both public and private funding have plummeted as federal policy changes have thrown the biotech sector into an era of ...

Tuberculosis (TB) is the world's deadliest infectious disease—and one of the hardest to cure. Standard treatment requires a ...

The London Stock Exchange isn’t packed to the brim with what some call ‘unicorn’ stocks, but this FTSE 250 biotech firm looks ...

Tuberculosis (TB) is the world's deadliest infectious disease—and one of the hardest to cure. Standard treatment requires a ...

NYUAD scientists uncover how one RNA tag may determine whether neurons grow, connect or misfire, shaping brain development ...